Risk Estimation in Non-Enhancing Glioma: Introducing a Clinical Score

SIMPLE SUMMARY: The preoperative risk estimation of non-enhancing suspected “low-grade” glioma (NEG) is key in determining the optimal timing of diagnosis and treatment to delay malignant progression and avoid undertreatment. The updated 2021 WHO classification brought new facets to glioma grading....

Descripción completa

Detalles Bibliográficos
Autores principales: Dao Trong, Philip, Kilian, Samuel, Jesser, Jessica, Reuss, David, Aras, Fuat Kaan, Von Deimling, Andreas, Herold-Mende, Christel, Unterberg, Andreas, Jungk, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177456/
https://www.ncbi.nlm.nih.gov/pubmed/37173969
http://dx.doi.org/10.3390/cancers15092503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177456/
https://www.ncbi.nlm.nih.gov/pubmed/37173969
http://dx.doi.org/10.3390/cancers15092503

Ejemplares similares